Laboratory Investigation is a premier academic journal published by Elsevier Science Inc, specializing in the fields of Pathology, Forensic Medicine, Cell Biology, and Molecular Biology. With its ISSN 0023-6837 and E-ISSN 1530-0307, this journal has been a significant contributor to scientific discourse since its inception in 1952, converging into its current form by 2024. It holds an impressive standing in its respective fields, featuring a 2023 Journal Rank of Q2 in both Cell Biology and Molecular Biology, and an elite Q1 ranking in Pathology and Forensic Medicine, reflecting its influence and quality of research, as seen in its Scopus ranks—17th out of 208 in Pathology and Forensic Medicine. Although it does not offer Open Access options, the journal remains a vital resource for researchers, professionals, and students who seek to disseminate and engage with high-caliber research findings. The importance of Laboratory Investigation is underscored by its commitment to advancing the understanding of laboratory and translational medicine, paving the way for innovations that enhance clinical practices.

ENDOCRINE PATHOLOGY is a premier journal published by HUMANA PRESS INC, dedicated to advancing the understanding of endocrine disorders through innovative research and clinical practices. With an impressive impact factor and consistently ranked in the Q1 quartile across multiple categories such as Endocrinology, Diabetes and Metabolism, as well as Pathology and Forensic Medicine, this journal serves as a pivotal resource for researchers and professionals in the field. The journal covers a broad spectrum of topics related to endocrine pathology, providing insights into mechanisms, diagnostics, and therapeutics that inform both clinical and laboratory practices. Although it does not offer open access, its rigorous peer-review process ensures the dissemination of high-quality, impactful research that shapes clinical strategies and enhances patient care. With distribution spanning from its inception in 1990 to 2024, ENDOCRINE PATHOLOGY stands at the forefront of endocrine research, making it an essential read for anyone involved in the study and treatment of endocrine disorders.

Pathologia is a prominent open-access journal dedicated to advancing the field of clinical and experimental pathology, published by ZAPORIZHZHYA STATE MEDICAL UNIVERSITY. Established in 2013, the journal aims to provide a platform for researchers, clinicians, and students to share innovative research, case studies, and reviews that are critical to understanding disease mechanisms and improving diagnostic and therapeutic strategies. With a steady commitment to high-quality research dissemination and accessibility, this journal serves as an essential resource for those in the medical and health sciences fields. Researchers engaging with Pathologia can explore a diverse range of topics, including histopathology, molecular pathology, and laboratory medicine, promoting both scholarly discussion and practical applications. The journal's open-access model ensures that vital research findings are freely available to the global academic community, fostering a collaborative environment that is crucial for the advancement of pathology as a discipline.

Cancer Cytopathology, published by Wiley, is an esteemed journal that plays a pivotal role in the fields of Cancer Research and Oncology. With a focus on the microscopic examination and analysis of cancerous cells, this journal serves as a crucial platform for disseminating high-quality research aimed at improving diagnostic techniques and therapeutic strategies. The journal holds an impressive Q2 ranking in both Cancer Research and Oncology as of 2023, emphasizing its influence and importance within the scientific community. Additionally, it is recognized in the top 76th percentile in Medicine - Oncology and the 63rd percentile in Cancer Research according to Scopus rankings. Operating from the United States, Cancer Cytopathology is dedicated to fostering cutting-edge research and exploration in cytopathology, providing essential insights into cancer progression and management. Researchers and practitioners alike will find this journal invaluable for staying on the forefront of advancements in cancer diagnostics.

CYTOPATHOLOGY is a pivotal journal published by WILEY, focusing on the dynamic field of cytopathology within the broader medical and pathological sciences. Founded in 1990, this journal has become a crucial resource for researchers, professionals, and students interested in the microscopic examination of cell samples for diagnostic purposes. With an ISSN of 0956-5507 and E-ISSN of 1365-2303, CYTOPATHOLOGY is indexed in Scopus, where it currently holds a rank of #113 in Pathology and Forensic Medicine and #43 in Histology, placing it in the Q3 quartile for multiple categories in 2023. The journal publishes original research, reviews, and clinical studies that advance the understanding and application of cytopathology and its significance in health care. Although not an Open Access journal, its commitment to providing high-quality research makes it an essential platform for disseminating knowledge in the field. Researchers and practitioners looking to stay at the forefront of cytopathology developments will find CYTOPATHOLOGY to be an invaluable resource.

JOURNAL OF DIAGNOSTIC MEDICAL SONOGRAPHY, published by SAGE PUBLICATIONS INC, is a critical platform for researchers, clinicians, and students in the field of sonography, offering insights and advancements in diagnostic imaging practices since its inception in 1985. With ISSN 8756-4793 and E-ISSN 1552-5430, this journal serves as a comprehensive resource addressing the latest trends, techniques, and technologies in radiological and ultrasound practices, despite being indexed in the lower quartiles yet maintaining a niche audience passionate about the evolution of sonographic methodologies. The journal's ongoing commitment to publishing high-quality research contributes significantly to its ranking within the competitive spheres of Radiology, Nuclear Medicine and Imaging and Radiological and Ultrasound Technology. As the field evolves, this journal aims to inspire dialogue, promote evidence-based practices, and enhance education among professionals dedicated to improving diagnostic accuracy and patient care in ultrasound technology.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, published by Taylor & Francis AS, serves as a pivotal platform for facilitating advanced research and discourse in the fields of Genetics, Molecular Biology, Molecular Medicine, and Pathology. With an impressive Impact Factor and a distinguished status as Q2 in multiple categories, along with a prestigious Q1 ranking in Pathology and Forensic Medicine (2023), this journal continues to attract contributions from leading experts and budding researchers alike. The journal aims to address critical developments in molecular diagnostics, providing insightful reviews that propel the understanding and application of diagnostic techniques in various medical contexts. Accessible to a diverse audience in the academic community, the journal emphasizes the importance of molecular diagnostics in both clinical and laboratory settings, promoting innovative methodologies and comprehensive evaluations of emerging technologies. With ongoing convergence of scientific discovery advancing rapidly from 2001 through 2024, EXPERT REVIEW OF MOLECULAR DIAGNOSTICS remains essential for those committed to furthering the fields of molecular diagnostics and healthcare advancements globally.

Annals of Diagnostic Pathology, published by Elsevier Science Inc, is a pivotal journal in the field of diagnostic pathology that has significantly contributed to the advancement of medical science since its inception in 1997. With an ISSN of 1092-9134 and E-ISSN of 1532-8198, this esteemed journal is positioned within the Q2 category in both Medicine (miscellaneous) and Pathology and Forensic Medicine, reflecting its high-quality research contributions, showcased by its ranking at #73 out of 208 in Scopus for the latter category. The journal's scope encompasses various aspects of diagnostic pathology, from innovative techniques to critical reviews of pathologic findings, making it an essential resource for researchers, medical professionals, and students dedicated to enhancing diagnostic accuracy and patient care. Although it does not currently offer open access options, its wide readership and impactful publications continue to influence clinical practices and research agendas. With a convergence period extending to 2024, Annals of Diagnostic Pathology remains a leading platform for disseminating valuable knowledge in this dynamic field.

Seminars in Diagnostic Pathology is a premier journal that has established itself as an essential resource in the field of pathology since its inception in 1984. Published by W B Saunders Co-Elsevier Inc, this journal boasts an impressive Q1 ranking in the pathology category for 2023, placing it in the top tier of medical journals worldwide. With a focus on diagnostic pathology, it offers a platform for groundbreaking research and advancements that bridge the gap between basic science and clinical practice. The journal is committed to publishing high-quality review articles, case reports, and expert opinions that provide valuable insights for professionals, researchers, and students alike. Although it operates on a subscription model, the journal's extensive impact is reflected in its Scopus rank (#56/208), with a remarkable 73rd percentile standing in the pathology and forensic medicine category. The journal's authoritative content not only aids in enhancing knowledge but also fosters an understanding of the evolving challenges and methodologies in diagnostic pathology, making it an indispensable tool for anyone dedicated to excellence in the field.

The Journal of Molecular Diagnostics is a premier publication in the fields of molecular medicine and pathology, published by Elsevier Science Inc. With an impressive impact factor and recognized as a Q1 journal in both Molecular Medicine and Pathology and Forensic Medicine, this journal is dedicated to advancing the understanding and application of molecular diagnostics in clinical practice. The journal features rigorous peer-reviewed research, comprehensive reviews, and cutting-edge methodologies that highlight novel diagnostic tests and biomarkers. Researchers, professionals, and students in the biomedical sciences are invited to explore its diverse array of articles and contribute to a growing body of knowledge critical for innovation in healthcare delivery. Located in the Netherlands, the journal has secure its position among the top-tier journals with its recent Scopus ranking of 20th out of 208 in Medicine Pathology and Forensic Medicine, reflecting a strong percentile ranking of 90th. With coverage spanning from 1999 to 2024, the Journal of Molecular Diagnostics remains a vital resource for anyone committed to the future of molecular research and diagnostics.